GB0908174D0 - Steroid containing composition and uses thereof - Google Patents

Steroid containing composition and uses thereof

Info

Publication number
GB0908174D0
GB0908174D0 GBGB0908174.6A GB0908174A GB0908174D0 GB 0908174 D0 GB0908174 D0 GB 0908174D0 GB 0908174 A GB0908174 A GB 0908174A GB 0908174 D0 GB0908174 D0 GB 0908174D0
Authority
GB
United Kingdom
Prior art keywords
containing composition
steroid containing
steroid
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0908174.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB0908174.6A priority Critical patent/GB0908174D0/en
Publication of GB0908174D0 publication Critical patent/GB0908174D0/en
Priority to PCT/GB2010/050776 priority patent/WO2010131038A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0908174.6A 2009-05-13 2009-05-13 Steroid containing composition and uses thereof Ceased GB0908174D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0908174.6A GB0908174D0 (en) 2009-05-13 2009-05-13 Steroid containing composition and uses thereof
PCT/GB2010/050776 WO2010131038A2 (en) 2009-05-13 2010-05-12 Steroid containing composition and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0908174.6A GB0908174D0 (en) 2009-05-13 2009-05-13 Steroid containing composition and uses thereof

Publications (1)

Publication Number Publication Date
GB0908174D0 true GB0908174D0 (en) 2009-06-24

Family

ID=40833889

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0908174.6A Ceased GB0908174D0 (en) 2009-05-13 2009-05-13 Steroid containing composition and uses thereof

Country Status (2)

Country Link
GB (1) GB0908174D0 (en)
WO (1) WO2010131038A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9931264B2 (en) 2013-11-13 2018-04-03 Thermawedge Enterprises, Inc. Apparatus for treating inflammatory symptoms associated with plantar fasciitis
WO2016007742A1 (en) 2014-07-09 2016-01-14 Riester Scott M Treating rotator cuff conditions
WO2017011762A1 (en) 2015-07-16 2017-01-19 Mayo Foundation For Medical Education And Research Treating rotator cuff conditions
CN111615395A (en) 2017-11-17 2020-09-01 莱诺翁股份有限公司 Stabilized ascorbic acid compositions and methods of use thereof
CN109674746A (en) * 2019-01-25 2019-04-26 北京太阳升高科医药研究股份有限公司 A kind of Edaravone infusion set

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2189M (en) * 1962-07-03 1963-12-09 Inst Rech Scient Anti-inflammatory and antiallergic composition.
US4080448A (en) * 1974-11-13 1978-03-21 Mirsky Louis H Method of treating cellular stress
JP2524709B2 (en) * 1985-09-26 1996-08-14 塩野義製薬株式会社 Analgesic and anti-inflammatory action enhancer
JPS62138432A (en) * 1985-12-12 1987-06-22 Shionogi & Co Ltd Stable tablet containing anti-inflammatory steroid
RO108413B1 (en) * 1993-11-26 1994-05-31 Neagoe Gheorghe Spray for anesthesia, disinfection and wounds, burnings and other cutaneous burnings scaring
WO2000012096A1 (en) * 1998-08-26 2000-03-09 Shionogi & Co., Ltd. Anti-inflammatory ointments
US6352691B1 (en) * 1999-05-12 2002-03-05 Robert Ortiz Therapeutic after-shave care lotion
US20030232797A1 (en) * 2002-06-06 2003-12-18 Forbes Medi-Tech Inc. Novel derivatives of androstane and androstene with ascorbic acid and use thereof in treating or preventing various conditions, diseases, and disorders
US6767534B1 (en) * 2002-09-20 2004-07-27 Robert Ortiz Post hair removal skin care lotion
US20060045850A1 (en) * 2004-08-30 2006-03-02 Qpharma, Llc Nasal delivery of cyclodextrin complexes of anti-inflammatory steroids
US20060194759A1 (en) * 2005-02-25 2006-08-31 Eidelson Stewart G Topical compositions and methods for treating pain and inflammation
CN1813765A (en) * 2005-12-06 2006-08-09 马清波 Medicine for treating toothache
WO2008104186A1 (en) * 2007-02-28 2008-09-04 Amal Mohamed Zakaria Al-Ansari Pharmaceutical composition comprising a steroid and vitamins
ES2316312B1 (en) * 2008-06-20 2010-02-08 Ignacio Umbert Millet DERMATOLOGICAL PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN INFLAMMATION PATHOLOGIES, SUCH AS FOR EXAMPLE DERMATITIS, ATOPICA DERMATITIS, VITILIGO, AREATA ALOPECIA, ACNE, PSORIASIS AND PRURITO, AND COMBINATIONS OF THE SAME.

Also Published As

Publication number Publication date
WO2010131038A3 (en) 2011-01-06
WO2010131038A2 (en) 2010-11-18

Similar Documents

Publication Publication Date Title
AP3106A (en) Antiparisitic dihydroazole compounds and compositions comprising same
PL2435503T3 (en) Curable silyl-group containing compositions and its use
HUE059796T2 (en) Psma-targeting compounds and uses thereof
HUE065114T2 (en) Monochlorotrifluoropropene compounds and compositions and methods using same
PL2475352T3 (en) Composition containing ultra-micronized palmitoyl - ethanolamide
EP2445894A4 (en) Ketal compounds and uses thereof
HK1144772A1 (en) Protopanaxadiol-type ginsenoside compositions and uses thereof
EP2511333A4 (en) Rubber composition and uses thereof
IL219470A0 (en) Compositions containing fractalknie-binding proteins and uses thereof
GB0903299D0 (en) Composition and methods
GB0915796D0 (en) Polymerase compositions and uses
GB0912468D0 (en) Composition and method
EP2490536A4 (en) Compositions and processes
GB0902429D0 (en) Compositions and their use
EP2514425A4 (en) Composition containing protopanaxatriol and protopanaxadiol
EP2410017A4 (en) Composition and element using same
GB0908174D0 (en) Steroid containing composition and uses thereof
GB0901494D0 (en) Compositions and Methods
ZA201200260B (en) Polyphenylsulphone-polytetrafluroethylene compositions and use thereof
GB0901667D0 (en) Composition and method
GB0909792D0 (en) Composition and uses thereof
GB2461611B (en) Composition and use thereof
EP2488624A4 (en) Stabilized surfactant-oxidant compositions and related methods
GB0902812D0 (en) Composition and use
GB0901899D0 (en) Compositions and uses

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)